Artículos por temáticas

Not So Smooth Sailing: FIG4-Related Disease Is a Differential Diagnosis of Rapid Onset Dystonia-Parkinsonism

Georgiades MJ, Wilson D, Garcia M, Boland-Freitas R, Morales-Briceño H, Mahant N, Fung VSC, Martin A.

Mov Disord Clin Pract. 2025 Aug;12 Suppl 2(Suppl 2):S10-S12. doi: 10.1002/mdc3.70049. Epub 2025 Mar 21.

Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials

Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group.

NPJ Parkinsons Dis. 2025 Aug 13;11(1):241. doi: 10.1038/s41531-025-01103-y.

Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson's disease with the first-in-class adaptive peptide AmyP53

Fantini J, Azzaz F, Aulas A, Chahinian H, Yahi N.

Sci Rep. 2025 Jul 3;15(1):23784. doi: 10.1038/s41598-025-07762-4.

Correction to: A new swallowing supplement for dysphagia in patients with Parkinson's disease

Oh E, Jee S, Kim BK, Lee JS, Cho K, Ahn S.

Neurol Sci. 2025 Aug;46(8):4101. doi: 10.1007/s10072-025-08285-6.

Author Correction: Mitochondria interaction networks show altered topological patterns in Parkinson's disease

Zanin M, Santos BFR, Antony PMA, Berenguer-Escuder C, Larsen SB, Hanss Z, Barbuti PA, Baumuratov AS, Grossmann D, Capelle CM, Weber J, Balling R, Ollert M, Krüger R, Diederich NJ, HeFeng FQ.

NPJ Syst Biol Appl. 2025 Jul 3;11(1):71. doi: 10.1038/s41540-025-00552-8.

Adaptive deep brain stimulation targeting the subthalamic nucleus in a patient with Parkinson's disease: A CARE compliant case report

Patel T, Hanani C, Noor A, Cheema S, Farhan M, Sohail R, Goyal A, David John J, Omole AE, Millis RM.

Medicine (Baltimore). 2025 Aug 22;104(34):e44130. doi: 10.1097/MD.0000000000044130.

Reply to: "Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS])"

Simuni T, Chahine LM, Poston KL, Kopil CM, Weintraub D, Dunn B, Marek K.

Mov Disord. 2025 Aug;40(8):1746-1747. doi: 10.1002/mds.30272. Epub 2025 Jun 27.

To See the Telemedicine Forest for Its Multicultural Trees. Comment on: In-Home Remote Assessment of the MDS-UPDRS Part III: Multicultural Development and Validation of a Guide for Patients

de Moraes Goraieb F, Teixeira-Dos-Santos D, Schuh AFS, de Paula Brandão PR, Silveira-Moriyama L.

Mov Disord Clin Pract. 2025 Jul;12(7):1033-1034. doi: 10.1002/mdc3.70073. Epub 2025 May 13.

Lesioning the Subthalamic Nucleus Using Magnetic Resonance Imaging-Guided Focused Ultrasound in Parkinson's Disease: Subthalamotomy Effectively Describes the Procedure

Paschen S, Natera-Villalba E, Rodríguez-Rojas R, Del Álamo M, Pineda-Pardo JA, Helmers AK, Hensler J, Deuschl G, Martínez-Fernández R, Obeso JA.

Mov Disord. 2025 Aug;40(8):1742-1743. doi: 10.1002/mds.30271. Epub 2025 Jun 23.

Parkinsonism Secondary to Cobra Bite: A Rare and Toxic Complication Due to Basal Ganglia Injury

Uppula S, Mustafa F, Agarwal A, Garg A, Damle N, Lekshmanan S, Srivastava AK, Garg D.

Mov Disord Clin Pract. 2025 Aug 1. doi: 10.1002/mdc3.70276. Online ahead of print.

A case of Frégoli syndrome following 24-hour levodopa-carbidopa intestinal gel infusion in a patient with Parkinson's disease undergoing STN-DBS

Ogata S, Kimura K, Abe K, Urago Y, Hayashi N, Kunii M, Ueda N, Tanaka F.

Clin Park Relat Disord. 2025 Jun 30;13:100364. doi: 10.1016/j.prdoa.2025.100364. eCollection 2025.

Reply to Comments on the Article "Machine Learning Predicts Risk of Falls in Parkinson's Disease Patients in a Multicenter Observational Study"

Malaguti MC, Longo C, Moroni M, Ragni F, Bovo S, Chierici M, Gios L, Avanzino L, Marchese R, Di Biasio F, Pardini M, Cerne D, Mandich P, Marenco M, Uccelli A, Giometto B, Jurman G, Osmani V, Network N

Eur J Neurol. 2025 Jul;32(7):e70281. doi: 10.1111/ene.70281.

Reply: To See the Telemedicine Forest for Its Multicultural Trees. Comment on: In-Home Remote Assessment of the MDS-UPDRS Part III: Multi-Cultural Development and Validation of a Guide for Patients

Tosin MHS, Sanchez-Ferro A, Wu RM, de Oliveira BGRB, Leite MAA, Suárez PR, Goetz CG, Martinez-Martin P, Stebbins GT, Mestre TA.

Mov Disord Clin Pract. 2025 Jul;12(7):1035-1036. doi: 10.1002/mdc3.70072. Epub 2025 May 13.

The Benefit of Exclusive Nocturnal Levodopa-Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease

Rivera-Sánchez M, Sánchez-Rodríguez A, Manrique L, Sierra M, González-Aramburu I, Sánchez-Peláez MV, Martínez M, López-Delgado A, Infante J.

Mov Disord Clin Pract. 2025 Jul 18. doi: 10.1002/mdc3.70237. Online ahead of print.

Research progress on the mechanisms of polysaccharides derived from traditional Chinese medicine in the treatment of Parkinson's disease

Zhou X, Pan Q.

Front Pharmacol. 2025 Aug 8;16:1566479. doi: 10.3389/fphar.2025.1566479. eCollection 2025.